Abacavir Sulfate (188062-50-2): A Detailed Overview

Wiki Article

Abacavir Base (CAS number 188062-50-2) is a potent antiviral typically utilized in the therapy of HIV infection and associated additional infections . It functions as a reverse transcriptase blocker , interfering with the HIV's duplication process . Administered frequently in combination other antiretroviral compounds, abacavir provides a critical part in suppressing the amount of virus and improving patient well-being . Careful human leukocyte testing for the HLA-B*57:01 allele is necessary prior to start of this therapy to reduce the risk of a hypersensitivity adverse effect.

Abarelix (183552-38-7): Properties and Uses

Abarelix, identified by the Chemical ID 183552-38-7, is a man-made polypeptide antagonist of gonadotropin-releasing hormone (GnRH). Its primary feature lies in its ability to initially stimulate, then rapidly desensitize GnRH receptors, leading to a significant lessening in gonadotropin output . Clinically , abarelix is applied primarily in the treatment of advanced prostate disease; however, research also explores emerging uses in other hormonal conditions and reproductive issues. The agent's structure allows for selective receptor interaction .

```text

Abiraterone Acetate (154229-18-2): Synthesis and Analytical Data

The preparation of Abiraterone Acetate, identified by the Chemical Abstracts Service Registry Number 154229-18-2, involves complex multistep chemical routes. Several reported methods exist, ATENOLOL  29122-68-7 often beginning with Androstadienedione and utilizing controlled oxidation and esterification steps. A typical procedure includes protecting group strategies to ensure correct regioselectivity. Analytical results, crucial for quality control, routinely employs high-performance chromatography (HPLC) for measurement of content. Nuclear Magnetic Resonance (NMR) spectroscopy confirms the chemical identity. Mass measurement delivers molecular weight validation. Other techniques, like infrared (IR) analysis, assist in characterization and are essential for production release.

```

```text

Understanding the CAS Numbers of Abacavir, Abarelix, and Abiraterone Acetate

Identifying chemical substances accurately is paramount in fields like medicine, research, and manufacturing. A crucial tool for this identification is the Chemical Abstracts Service (CAS) registry number – a unique numerical identifier assigned to every distinct chemical compound. Let's examine the CAS numbers for three significant pharmaceuticals: Abacavir, Abarelix, and Abiraterone Acetate. Understanding these identifiers aids in correct referencing and prevents errors within scientific literature and regulatory documentation. Abacavir, a nucleoside reverse transcriptase inhibitor used to treat HIV, holds the CAS number 60242-78-0. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist employed in prostate cancer treatment, is identified by the CAS number 5490-02-9. Finally, Abiraterone a CYP17 inhibitor used in metastatic prostate cancer, possesses the CAS number 857342-50-7. Precisely utilizing these numbers ensures clarity and consistency when discussing these medications.

```

Key Information on Abacavir , Abarelix , and Abiraterone Drug

These therapies represent distinct approaches in medicine. Abacavir is a medicine primarily applied to combat HIV illness, often alongside other medications. Abarelix for Treatment is a drug that works as a GnRH antagonist , typically utilized to manage prostate growths before operation . Lastly, Abiraterone Acetate is another treatment used to treat advanced prostate cancer , specifically targeting testosterone creation. Always ask a physician for detailed information and advice regarding any medicine .

Pharmaceutical Analysis: Abacavir, Abarelix Product, Abiraterone Acetate and Their Registration Numbers

Examining key pharmaceutical compounds requires some clear identification. Notably, Abacavir Sulfate, used in HIV treatment, carries a Registration Code of 3870-92-6. Similarly, Abarelix, the hormone inhibitor administered during prostate cancer management, exhibits the Registration Identifier 64347-82-2. To conclude, Abiraterone Acetate, a crucial compound in metastatic male lesions, is associated with the Registration Reference 864930-63-3. Such codes serve vital tools in accurate pharmaceutical identification and investigation.

Report this wiki page